Topic Hub
3 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 3 of 3 clinical reviews.
Complete regulatory history of levothyroxine (Synthroid) across FDA, EMA, and global agencies, including approval timelines, label updates, and post-market surveillance findings.
Read clinical reviewA detailed review of FDA Adverse Event Reporting System (FAERS) data for Synthroid (levothyroxine), including the most frequently reported safety signals, label changes, and clinical context for prescribers and patients.
Read clinical reviewSynthroid faced decades of legal battles over bioequivalence, FDA approval delays, and patent disputes. This article covers the full regulatory timeline, key lawsuits, and what they mean for patients on levothyroxine.
Read clinical review